Osteoarthritis in 2010
Cartilage matrix degradation: an appropriate therapeutic target in osteoarthritis
Tanezumab: best pain treatment yet?
Genetic factors may have a role in the progression of osteoarthritis
Study suggests that supplements to combat joint pain are taken by millions but do not work
Exercise improves long-term outcomes in osteoarthritis
Ultrasound is an effective technique for identifying erosions and inflammation in hand osteoarthritis
Bone marrow lesions may predict future joint replacement
Bone marrow ‘edema’ lesions may represent true edema
Glucosamine sulfate for knee osteoarthritis: science and evidence-based use
The burden of osteoarthritis:the societal and the patient perspective
Experimental models of osteoarthritis: usefulness in the development of disease-modifying osteoarthritis drugs/agents
Imaging of knee osteoarthritis
Is there a role for bone tissue in osteoarthritis?
Synovium in the pathophysiology of osteoarthritis
Rehabilitation in osteoarthritis
Are biologics a treatment option in osteoarthritis?
Roflumilast decreases the frequency of underestimated lung exacerbations
Multiple sclerosis drug fingolimod approved by US FDA
US FDA approves Tekamlo™ for the treatment of high blood pressure
CYT107 enters Phase II clinical trial in HIV-infected patients
Drug Approvals August to October 2010
Dapoxetine: a pharmacological therapy for the treatment of premature ejaculation
Transplantation of cord blood stem cells for treating hematologic diseases and strategies to improve engraftment
Acknowledgements